Prestige Consumer Healthcare
354 hedge funds and large institutions have $3.18B invested in Prestige Consumer Healthcare in 2025 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 129 increasing their positions, 139 reducing their positions, and 44 closing their positions.
4.1% more ownership
Funds ownership: 103.27% → 107.36% (+4.1%)
7% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 44
0% more capital invested
Capital invested by funds: $3.17B → $3.18B (+$11.6M)
1% less funds holding
Funds holding: 357 → 354 (-3)
7% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 139
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
+$31.8M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$31.1M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$17.9M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$17.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$101M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$40M |
| 3 |
JP Morgan Chase
New York
|
-$14.1M |
| 4 |
Renaissance Technologies
New York
|
-$8.12M |
| 5 |
Goldman Sachs
New York
|
-$6.93M |
PBH Hedge Fund Activity: Q4 2025 in Review
354 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2025, worth a combined $3.18B — up 0.36% from $3.17B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new PBH positions and 44 closed out — a net gain of 3 holders — while 129 added to existing stakes and 139 trimmed.
The largest buyer was Nordea Investment Management, adding an estimated $31.8M. The largest seller was Macquarie Group, exiting entirely with an estimated $101M sold.
- 354 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2025, down from 357 in Q3 2025.
- Funds reported $3.18B of Prestige Consumer Healthcare stock for Q4 2025, up 0.36% quarter-over-quarter.
- 47 funds opened new Prestige Consumer Healthcare positions in Q4 2025 and 44 closed out, a net change of +3 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2025 was Nordea Investment Management, an estimated $31.8M added.
- The largest Prestige Consumer Healthcare seller in Q4 2025 was Macquarie Group, an estimated $101M sold.
Based on aggregated 13F filings for Q4 2025.